Your browser does not fully support modern features. Please upgrade for a smoother experience.
Peptide Aptamer: History
Please note this is an old version of this entry, which may differ significantly from the current revision.
Contributor: Yu Peng

A peptide aptamer is a selected peptide ligand that binds a specific protein, typically through a variable amino acid sequence constrained within a stable protein scaffold [1][2]. In the original system, twenty-residue sequences were inserted into the exposed active-site loop of Escherichia coli thioredoxin, and a yeast two-hybrid screen identified variants recognizing cyclin-dependent kinase 2 [1]. The scaffold restricts the conformations available to the displayed sequence while supporting its intracellular expression. Selection links a binding phenotype to the DNA encoding the ligand, allowing individual aptamers to be recovered and characterized [1][2]. Binding can interfere with a target's catalytic activity or molecular interactions, providing a means to perturb protein function without eliminating the protein itself [3][4]. Specificity tests distinguish recognition of the intended target from binding to related proteins or assay components [2]. Biologically active aptamers can support target validation and identify interaction surfaces for subsequent small-molecule screening, including assays in which compounds displace the bound aptamer [4].

  • peptide aptamer
  • thioredoxin scaffold
  • protein binding
  • target validation

References

  1. Pierre Colas; Barak Cohen; Timm Jessen; Irina Grishina; John McCoy; Roger Brent; Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature 1996, 380, 548-550. [CrossRef]
  2. Marc B T Bickle; Eric Dusserre; Olivier Moncorgé; Hélène Bottin; Pierre Colas; Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures. Nat. Protoc. 2006, 1, 1066-1091. [CrossRef]
  3. Margaret Crawford; Rob Woodman; Paul Ko Ferrigno; Peptide aptamers: Tools for biology and drug discovery. Brief. Funct. Genom. Proteom. 2003, 2, 72-79. [CrossRef]
  4. Ivan C. Baines; Pierre Colas; Peptide aptamers as guides for small-molecule drug discovery. Drug Discov. Today 2006, 11, 334-341. [CrossRef]
More
This entry is offline, you can click here to edit this entry!
Write an Entry